Suven Life Sciences Ltd

NSE: SUVEN · BSE: 530239 · Healthcare · 30 announcements

Share price: ₹307.00
Market cap: ₹8,675 Cr
Revenue (annual): ₹7.11 Cr
Net profit (annual): ₹-276.3 Cr
P/E (TTM): -24.6×Sector 53.1×
Promoter holding: 65.47%-4.68% QoQ
FII holding: 0.48%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Business Update 3 Annual General Meeting 3 Board Meeting Outcome 2 Promoter Selling (Off-Market) 1 Management Change 1 Fund Raise 1 Financial Results 1 Employee Stock Options 1 Capital Structure Change 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

8 Jul 2026 16:51 IST NSE

Board Meeting Outcome

Suven Life Sciences Board Meeting Outcome

Suven Life Sciences' Board approved converting warrants into 1.85 crore shares for Rs.24.88 Cr. It also reappointed an Independent Director for a 5-year term.

Value: ₹24.88 Cr

Read the filing ↗

8 Jul 2026 14:59 IST BSE

Board Meeting Outcome

Suven Life Sciences Board Meeting Outcome

SUVEN Life Sciences Limited re-appointed Mr. Vajja Sambasiva Rao as Non-Executive Independent Director for 60 months. The board meeting was held on 08‑07‑2026.

Read the filing ↗